Completed MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) NCT06455826 Conditions Eye Diseases, Eye Diseases, Hereditary, Retinal Degeneration, +4 more Locations University of Florida Health — Jacksonville, Florida, United States University of Michigan Kellogg Eye Center — Ann Arbor, Michigan, United States Oregon Health and Science University - Casey Eye Institute — Portland, Oregon, United States Retina Foundation of the Southwest — Dallas, Texas, United States View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 NCT06852963 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases Hereditary, +7 more Locations University of Florida College of Medicine — Jacksonville, Florida, United States Bascom Palmer Eye Institute - University of Miami — Miami, Florida, United States Kellogg Eye Center - University of Michigan — Ann Arbor, Michigan, United States Casey Eye Institute - OHSU — Portland, Oregon, United States View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Natural History Study of Retinitis Pigmentosa Type 11 NCT04805658 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +7 more Locations Department of Ophthalmology, Oslo University Hospital — Oslo, Norway View Trial Details
